Alcon Inc. (ALC)
ALC trades on NYSE in Health Care, Ophthalmic Goods. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026. Revenue: SEC 20-F (ifrs-full:Revenue), period ending 2025-12-31, https://www.sec.gov/Archives/edgar/data/1167379/000116737926000014/0001167379-26-000014-index.htm. Net income: SEC 20-F (ifrs-full:ProfitLossAttributableToOwnersOfParent), period ending 2025-12-31.
Profile
| Field | Value |
|---|---|
| Ticker | ALC on NYSE |
| Sector | Health Care |
| Industry | Ophthalmic Goods |
| Country | Switzerland |
| IPO year | 2019 |
| SEC CIK | 0001167379 |
| SEC industry code | Ophthalmic Goods |
| Incorporated in | V8 |
Financials · 2025
| Line | Value |
|---|---|
| Revenue | $10.4B |
| Net income | $980.0M |
| Operating income | Not in SEC XBRL data |
| Net margin | 9.4% |
| Operating margin | Operating income not reported |
| Revenue growth | No prior-year revenue to compare |
| Cash | Not in SEC XBRL data |
| Total assets | Not in SEC XBRL data |
| P/E (computed) | 32.1× |
| P/S (computed) | 3.0× |
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document ALCON, INC. | 424B5 | 2002-03-21 |
| Latest annual report | 20-F | 2026-02-24 |
| Latest quarterly / interim | 6-K | 2026-08-10 |
| Latest proxy | DEFM14A | 2025-08-05 |
Source: SEC EDGAR submissions feed, 527 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | +1.3% |
| 1 month | -5.8% |
| 3 months | -9.6% |
| Year to date | -19.0% |
| 1 year | -12.1% |
| From 52-week high | -26.8% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Ophthalmic Goods
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| COO | The Cooper Companies Inc. | $54.59 | -1.72% | $10.4B |
| BLCO | Bausch + Lomb Corporation Common Shares | $15.81 | -1.62% | $5.6B |
| WRBY | Warby Parker Inc. | $26.52 | +2.04% | $3.3B |
| EYE | National Vision Holdings Inc. | $17.04 | -0.18% | $1.3B |
| STAA | STAAR Surgical Company | $21.50 | -2.32% | $1.1B |
| RXST | RxSight Inc. | $4.53 | -2.79% | $188.4M |
| LUCY | Innovative Eyewear Inc. | $0.8524 | -3.43% | $7.4M |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier